Septodont Holding Drug Patent Portfolio
Septodont Holding owns 1 orange book drug protected by 5 US patents Given below is the list of Septodont Holding's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7575757 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof | 21 Apr, 2025 | Active |
| US7569230 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof | 17 Oct, 2023 | Expired |
| US7229630 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof | 20 Jun, 2023 | Expired |
| US6764678 | Local anesthetic methods and kits | 11 May, 2021 | Expired |
| US6872390 | Local anesthetic methods and kits | 11 May, 2021 | Expired |
Latest Legal Activities on Septodont Holding's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Septodont Holding.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 Feb, 2021 | US7575757 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 25 Jan, 2021 | US7569230 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 03 Dec, 2018 | US7229630 |
| Request for Trial Granted in Part | 06 Nov, 2016 | US7575757 |
| Petition Requesting Trial | 06 Nov, 2016 | US7575757 |
| Termination or Final Written Decision | 06 Nov, 2016 | US7575757 |
|
Request for Trial Granted
Critical
| 08 Jul, 2016 | US7575757 |
| Petition Requesting Trial | 08 Jul, 2016 | US7575757 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 30 Dec, 2010 | US7229630 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 18 Aug, 2009 | US7575757 |
|
Recordation of Patent Grant Mailed
Critical
| 18 Aug, 2009 | US7575757 |
|
Recordation of Patent Grant Mailed
Critical
| 04 Aug, 2009 | US7569230 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 04 Aug, 2009 | US7569230 |
|
Issue Notification Mailed
Critical
| 29 Jul, 2009 | US7575757 |
|
Issue Notification Mailed
Critical
| 15 Jul, 2009 | US7569230 |
Septodont Holding's Family Patents
Septodont Holding drugs have patent protection in a total of 12 countries. It's US patent count contributes only to 43.5% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Septodont Holding Drug List
Given below is the complete list of Septodont Holding's drugs and the patents protecting them.
1. Oraverse
Oraverse is protected by 5 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7575757 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
21 Apr, 2025
(6 months from now)
| Active |
| US7569230 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
17 Oct, 2023
(11 months ago)
| Expired |
| US7229630 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
20 Jun, 2023
(1 year, 3 months ago)
| Expired |
| US6764678 | Local anesthetic methods and kits |
11 May, 2021
(3 years ago)
| Expired |
| US6872390 | Local anesthetic methods and kits |
11 May, 2021
(3 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Oraverse's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List